Place of radiation-therapy of brest cancer treatment - Actual and future indications;Place de la radiothérapie dans le traitement du cancer du sein: Indications actuelles et perspectives

Revue Medicale de Liege

Volumn 61, Issue 9, 2006, Pages 623-631

  Meyns, M ^a   Jansen, N ^a   Deneufbourg, J M ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Breast cancer; Guidelines; Radiation therapy

Indexed keywords

ANTHRACYCLINE; ANTIARRHYTHMIC AGENT; CHAMOMILE; CLONAZEPAM; CORTICOSTEROID DERIVATIVE; GABAPENTIN; KAMILLOSAN; SULFADIAZINE SILVER;

AXILLARY LYMPH NODE; BRACHYTHERAPY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; HORMONAL THERAPY; HUMAN; MASTECTOMY; MEDICAL PRACTICE; PECTORAL MUSCLE; PRACTICE GUIDELINE; REVIEW;

BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FORECASTING; HUMANS;

EID: 33749674149     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Kurtz JM.- Radiotherapy in the curative treatment of breast cancer: current status and future trends. An opinion sample on radiation oncologists active in breast cancer research. Radiotherapy and Oncology, 1994, 32, 21-28.
2. Van der Schueren E.- Factors in decision making in the treatment of breast cancer. Radiotherapy and Oncology, 2000, 55, 205-216.
3. Goldhirsch A, Glick JH, Gelber RD, et al. and Panel members.- Meeting Highlight: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005. Annals of Oncology, 2005, 16, 1569-1583.
4. Bartelink H, Horiot JC.- Factors in decision making in the treatment of breast cancer. Radiotherapy and Oncology, 2000, 55, 217-218.
5. Van de Steene J, Soete G, Storme G.- Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. Radiotherapy and Oncology, 2000, 55, 263-272.
6. Overgaard M, Jensen M, Overgaard J, et al.- Postoperative radiotherapy in high-risk post menopausal breast cancer patients given tamoxifen: Danish Breast Cancer Cooperative Group DGCG 82c randomised. Lancet, 1999, 353, 1641-1648.
7. Fisher ER, M. D., Costantino J, et al.- Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Cancer, 1996, 1403-1416.
8. Silverstein M. J.- The USC/Van Nuys Prognostic Index, in Ductal Carcinoma in situ of the breast - in Silverstein M J, Editor. Ductal Carcinoma in situ of the breast, 2nd Edition, Lippincott Williams and Wilkins, Philadelphia, 2002, 459-473.
9. Bartelink H, Horiot JC, Poortmans P, et al.- for the European Organization for Research ant Treatment of Cancer Radiotherapy and Breast Cancer Groups - Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. The New England Journal of Medicine, 2001, 345, 1378-1387.
10. Poortmans P, Bartelink H, Horiot JC et al.- on behalf of the EORTC Radiotherapy and Breast Cancer Groups - The influence of the boost technique on local control in breast conserving treatment in the EORTC "boost versus no boost" randomised trial. Radiotherapy and Oncology, 2004, 72, 25-33.
11. Vrieling C, Collette L, Fourquet A, et al.- on behalf of the EORTC Radiotherapy and Breast Cancer Cooperative Groups - The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC "boost vs. no boost" trial. Radiotherapy and Oncology, 2000, 55, 219-232.
12. Gilligan D, Hendry JA, Yarnold JR.- The use of ultrasound to measure breast thickness to select electron energies for breast boost radiotherapy. Radiotherapy and Oncology, 1994, 32, 265-267.
13. Feigenberg SJ, Price Mendenhall N, Benda RK, et al.- Postmastectomy radiotherapy: patterns of recurrence and long-term disease control using electrons. Int. J. Radiation Oncology Biol. Phys, 2003, 56, 716-725.
14. Truong PT, Olivotto IA, Speers CH, et al.- A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer. Int. J. Radiation Oncology Biol. Phys, 2004, 58, 797-804.
15. Chawla AK, Kachnic LA, Taghian AG, et al.- Radiotherapy and breast reconstruction: complications and cosmesis with tram versus tissue expander/implant. Int. J. Radiation Oncology Biol. Phys, 2002, 54, 520-526.
16. Fisher BJ, Perera FE, Cooke AL, et al.- Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy? Int. J. Radiation Oncology Biol. Phys, 1997, 38, 551-559.
17. Truong PT, Bernstein V, Wai E, et al.- Age-related variations in use of axillary dissection: a survival analysis of 8038 women with T1-ST2 breast cancer. Int. J. Radiation Oncology Biol. Phys, 2002, 54, 794-803.
18. Grills IS, Kestin LL, Goldstein N, et al.- Risk factors for regional nodal failure after breast-conserving therapy : regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes. Int. J. Radiation Oncology Biol. Phys, 2003, 56, 658-670.
19. Fortin A, Dagnault A, Larochelle M, et al.- Impact of locoregional radiotherapy in node-positive patients treated by breast-conservative treatment. Int. J. Radiation Oncology Biol. Phys, 2003, 56, 1013-1022.
20. Cody HS 3rd, Borgen PI, Tan LK.- Redefening prognosis in node-negative breast cancer: can sentinel lymph node biopsy raise the threshold for systemic adjuvant therapy? Ann Surg Oncol, 2004, 11, 227-230.
21. Pierce LJ, Oberman HA, Strawderman MH, et al.- Microscopic extracapsular extension in the axilla: is thin an indication for axillary radiotherapy? Int. J. Radiation Oncology Biol. Phys, 1995, 33, 253-259.
22. Chen SC, Chen MF, Hwang TL, M. et al.- Prediction of supraclavicular lymph node metastasis in breast carcinoma. Int. J. Radiation Oncology Biol. Phys, 2002, 52, 614-619.
23. Lievens Y, Ph. D, Kesteloot K, Van den Bogaert W.- Economic consequence of local control with radiotherapy: cost analysis of internal mammary and medial supraclacivular lymph node radiotherapy in breast cancer. Int. J. Radiation Oncology Biol. Phys, 2005, 63, 1122-1131.
24. Kaija H, Maunu P.- Tangential breast irradiation with or without internal mammary chain irradiation: results of a randomized trial. Radiotherapy and Oncology, 1995, 36, 172-176.
25. Lievens Y, Poortmans P, Van den Bogaert W.- A glance on quality assurance in EORTC study 22922 evaluating techniques for internal mammary and medial supraclavicular lymph node chain irradiation in breast cancer. Radiotherapy and Oncology, 2001, 60, 257-265.
26. Touboul E, Lefranc JP, Blondon J, et al.- Multidisciplinary treatment approach to locally advanced noninflammatory breast cancer using chemotherapy and radiotherapy with or without surgery. Radiotherapy and Oncology, 1992, 25, 167-175.
27. Fourquet A, Cutuli B, Luporsi E, et al.- Standards, options et recommandations 2001 pour la radiothérapie des patientes atteintes d'un cancer du sein infiltrant non métastatique, mise à jour. Cancer/Radiother, 2002, 6, 238-258.
28. Ortholan C, Hannoun-Lévi JM, Ferrero JM, et al.- Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients. Int. J. Radiation Oncology Biol. Phys, 2005, 61, 154-162.
29. Delanian S, Lefaix JL.- The radiation-induced fibroatrophic process: therapeutic perspective via the antioxydant pathway. Radiotherapy and Oncology, 2004, 73, 119-131.
30. Polgar C, Major T, Fodor J, et al.- High-dose-rate brachyterapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study. Int. J. Radiation Oncology Biol. Phys, 2004, 60, 1173-1181.